Harvard Bioscience Sees FY2026 Sales $89.147M-$90.877M vs $88.600M Est.
Harvard Bioscience (NASDAQ: HBIO ) sees FY2026 sales of $89.147 million-$90.877 million vs $88.600 million analyst estimate. Raises Full Year 2026 Revenue Guidance to 3%-5% Year Over Year Growth.
Harvard Bioscience (NASDAQ: HBIO ) sees FY2026 sales of $89.147 million-$90.877 million vs $88.600 million analyst estimate.
Raises Full Year 2026 Revenue Guidance to 3%-5% Year Over Year Growth.